EPISODE-13: DR.MUHAMED ALY RIFAI, MD: THE STATE OF OVER MEDICATED AMERICA!! RETHINKING PSYCHOTROPIC MEDICATIONS

“..STRUCTURED TAPPERING ISN’T JUST SCIENCE…IT’S STEWARDSHIP..”

by

dr. mohamed aly rifai,md., clinical psychiatrist

from youarewithinthenorms.com

NORMAN J CLEMENT RPH., DDS, NORMAN L. CLEMENT PHARM-TECH, MALACHI F. MACKANDAL PHARMD, BELINDA BROWN-PARKER, IN THE SPIRIT OF JOSEPH SOLVO ESQ., INC., SPIRIT OF REV. IN THE SPIRIT OF WALTER R. CLEMENT BS., MS, MBA. HARVEY JENKINS, MD, PH.D., IN THE SPIRIT OF C.T. VIVIAN, JELANI ZIMBABWE CLEMENT, BS., M.B.A., IN THE SPIRIT OF THE HON. PATRICE LUMUMBA, IN THE SPIRIT OF ERLIN CLEMENT SR., EVELYN J. CLEMENT, WALTER F. WRENN III., MD., JULIE KILLINGSWORTH, RENEE BLARE, RPH, DR. TERENCE SASAKI, MD LESLY POMPY MD., CHRISTOPHER RUSSO, MD., NANCY SEEFELDT, WILLIE GUINYARD BS., JOSEPH WEBSTER MD., MBA, BEVERLY C. PRINCE MD., FACS., NEIL ARNAND, MD., RICHARD KAUL, MD., IN THE SPIRIT OF LEROY BAYLOR, JAY K. JOSHI MD., MBA, AISHA GARDNER, ADRIENNE EDMUNDSON, ESTER HYATT PH.D., WALTER L. SMITH BS., IN THE SPIRIT OF BRAHM FISHER ESQ., MICHELE ALEXANDER MD., CUDJOE WILDING BS, MARTIN NJOKU, BS., RPH., IN THE SPIRIT OF DEBRA LYNN SHEPHERD, BERES E. MUSCHETT, STRATEGIC ADVISORS

Rethinking Psychotropic MedicationS and Mental Health Reform

This video transcript from “The Virtual Psychiatrist” highlights a significant issue in U.S. mental healthcare: a widespread over-reliance on psychotropic medications, partly due to short appointment times that prevent addressing root causes. A critical problem is the lack of formal guidelines and physician training on safely tapering patients off these drugs, often leaving individuals to navigate confusing withdrawal symptoms and potential relapse alone. 

“…MORE BANDAIDS ON BULLET HOLES…”

This collection of excerpts from a podcast episode features a discussion on the challenges and complexities surrounding the use of psychotropic medications in the United States. The conversation highlights the alarming number of Americans on these drugs, suggesting that the current healthcare system prioritizes quick fixes over addressing the root causes of distress. A significant concern raised is the lack of standardized guidance for safely tapering off medications, leaving both patients and physicians in difficult situations with potential withdrawal symptoms or confusion about relapse.

The speakers argue for a paradigm shift towards a more holistic and patient-centered approach, emphasizing the need for better training, longer appointment times, and integrated care that includes therapy and support systems. They also contrast the U.S. approach with that of the UK, where structured tapering protocols are more established, and touch upon the role of the pharmaceutical industry’s incentives and the importance of patient autonomy within a clinically supervised framework.

Study Guide

This study guide is designed to help you review the key concepts and arguments presented in “Episode 13: Rethinking Psychotropic Medication and Mental Health Reform.” The episode explores the current state of psychotropic medication use in the US, identifies systemic issues within the healthcare system that contribute to over-reliance on medication, and discusses the critical need for improved approaches to deprescribing and holistic mental health care.

Key Themes and Arguments:

• High Prevalence of Psychotropic Medication Use: A significant percentage of US adults are on psychotropic medications, a number that surged during the pandemic but reflects deeper systemic issues.
• Systemic Factors Contributing to Over-Reliance: The current healthcare system, particularly short “med management” visits, pressures physicians towards quick fixes like prescribing, leaving little time to address root causes or discuss long-term strategies like tapering.
• Lack of Formal Tapering Guidelines in the US: Unlike countries like the UK with structured guidance (e.g., NICE guidelines for antidepressants), the US lacks formal protocols for safely tapering off psychotropic medications. This leaves physicians and patients without a roadmap and can lead to unintended long-term use by default.
• Challenges and Risks of Tapering: Patients often face withdrawal symptoms that can mimic their original conditions or be confusingly similar, making it difficult to discern the cause of distress. Tapering off medications is a complex process, both physiologically and psychologically, requiring time, patience, and individualized approaches.
• The Need for Responsible Deprescribing: There is a critical need for a paradigm shift that emphasizes not just prescribing but also responsible deprescribing. This requires time, patience, and a broader perspective that includes therapy, support systems, and addressing social determinants of mental distress.
• The Role of Grassroots Movements vs. Clinical Guidance: While patient-led movements advocating for medication cessation can be empowering, tapering without professional clinical supervision is risky due to potential withdrawal symptoms, relapse, or worse. Collaboration between grassroots efforts and clinicians is essential for patient safety.
• Systemic Inertia and Lack of Resources: The lack of structured tapering approaches in the US is attributed to systemic inertia, a focus on short-term symptom control over long-term patient well-being, and the lack of time and training for physicians in withdrawal management.
• The Importance of Integrating Behavioral Health and Primary Care: Addressing mental health requires a holistic approach that integrates behavioral health with primary care, considering social factors, lifestyle changes, and therapy alongside medication.
• The Influence of Pharmaceutical Companies: Pharmaceutical companies have little incentive to fund research on medication discontinuation, as there is no profit in teaching people how to stop using their products.
• Patient Inclusion and Autonomy: Patients are often left out of the decision-making process regarding their medication, leading to feelings of uncertainty and a lack of agency. A more collaborative approach is needed, involving patients in discussions about both starting and stopping medications.
• Rethinking Healthcare and Building Trust: Fundamental reform is needed to shift the healthcare narrative from purely treating illness to preventing it and promoting overall well-being. Rebuilding trust in the healthcare system requires showing tangible outcomes and prioritizing patient needs.
• Cultural Shift in Mental Health Care: The conversation calls for a cultural shift in how mental health care is approached, moving towards valuing recovery over mere symptom management and embracing a holistic, patient-centered model.

Quiz

Answer each question in 2-3 sentences.

1. According to the podcast, what is the approximate percentage of adults in the US currently on psychotropic medications? What does this number reflect?
2. How did the pandemic specifically impact the rate of psychotropic medication use in the US?
3. What is one major criticism of the standard “med management” visits in the US healthcare system?
4. What is a significant difference between mental healthcare guidelines in the UK (e.g., NICE guidelines) and those in the US concerning psychotropic medication?
5. Why is the process of tapering off psychotropic medication often difficult and confusing for patients?
6. What is a potential risk of individuals tapering off psychiatric medications without professional clinical supervision?
7. Beyond prescribing, what broader perspective is needed for responsible deprescribing?
8. How might the focus of pharmaceutical companies influence the availability of research on medication discontinuation?
9. According to the discussion, how does the US health insurance model contribute to the challenges of providing comprehensive mental healthcare?
10. What does the podcast suggest is needed for a cultural shift in how mental health care is approached in the US?

Quiz Answer Key

1. Nearly a quarter of adults in the US are on psychotropic medications. This number reflects the state of national mental health and potentially systemic issues within the healthcare system.
2. The pandemic acted as a trigger, contributing to a surge in psychotropic medication use due to isolation, stress, and the resulting “perfect storm.”
3. Med management visits, often as short as 15 minutes, do not allow physicians enough time to address the root causes of a patient’s distress or discuss comprehensive long-term treatment strategies.
4. The UK, with guidelines like NICE, has structured, systematic guidance for tapering antidepressants, while the US lacks formal, widespread guidelines for safely tapering psychotropic medications.
5. Patients can experience withdrawal symptoms that closely mimic their original conditions, making it difficult to distinguish between withdrawal and a potential relapse.
6. Without professional guidance, individuals tapering off medications risk experiencing severe withdrawal symptoms, potential relapse of their condition, or other adverse effects.
7. Responsible deprescribing requires a broader perspective that includes time, patience, therapy, support systems, and addressing the social factors contributing to mental distress.
8. Pharmaceutical companies have little financial incentive to fund research on discontinuing medications, as their profit comes from people using their products long-term.
9. The current insurance model incentivizes short, frequent appointments focused on medication management rather than providing time for in-depth conversations about long-term treatment or tapering strategies.
10. A cultural shift is needed to move towards valuing recovery over mere symptom management, bringing patients into decision-making, educating clinicians on deprescribing, and focusing on sustainable health.

Essay Format Questions

These questions are designed to encourage you to think critically about the material and synthesize the different arguments presented in the podcast.

1. Discuss the systemic factors within the US healthcare system that contribute to the over-reliance on psychotropic medications and the challenges associated with safe deprescribing. Compare and contrast this with approaches discussed in other countries.
2. Analyze the potential benefits and risks of grassroots movements focused on medication cessation. How can collaboration between these movements and clinical professionals address the safety concerns raised in the podcast?
3. Explore the complex experience of patients attempting to taper off psychotropic medications, including the physiological and psychological challenges they face. How does the lack of structured guidance and support exacerbate these difficulties?
4. Evaluate the role of pharmaceutical companies and the current health insurance model in perpetuating the focus on medication management over holistic mental health care. What changes are needed to shift these incentives?
5. Propose concrete steps or policy changes that could facilitate a cultural shift in US mental healthcare, moving towards a more patient-centered, recovery-oriented model that prioritizes responsible deprescribing and addresses social determinants of health.

Glossary of Key Terms

• Psychotropic Medications: Drugs that affect the mind, emotions, or behavior, used to treat mental health conditions.
• Med Management Visits: Short clinical appointments focused primarily on reviewing and adjusting a patient’s prescribed medications.
• Tapering: The process of gradually reducing the dose of a medication over time to minimize withdrawal symptoms.
• Deprescribing: The systematic process of identifying and discontinuing medications where the harms outweigh the benefits or where they are no longer aligned with a patient’s goals of care.
• Withdrawal Symptoms: Physical and psychological effects that can occur when a person stops taking or reduces the dose of a medication.
• Relapse: The return of symptoms of a mental health condition after a period of improvement.
• NICE Guidelines: Guidelines developed by the National Institute for Health and Care Excellence in the UK, offering evidence-based recommendations for health and social care.
• Systemic Inertia: The tendency for a system to resist change, often due to established practices, structures, or priorities.
• Social Determinants of Health: The conditions in the environments where people are born, live, learn, work, play, worship, and age that affect a wide range of health, functioning, and quality-of-life outcomes and risks.
• Behavioral Health: A broad term that includes mental health, substance use, and physical health behaviors.
• Holistic Care: An approach to healthcare that considers the whole person, including their physical, mental, emotional, and social well-being.
• Patient Autonomy: The right of a patient to make decisions about their own medical care.
• Stewardship: The responsible planning and management of resources.

THE ANAND-CLEMENT RULE AND THE RISE OF ARTIFICIAL STUPIDITY (AS): [AI(alg*) =AS]

DONATE LEGAL DEFENSE

OR SEND

TO CASH APP:$docnorm

ZELLE 3135103378

ALL WATCHED OVER BY MACHINES OF LOVING GRACE

BE SURE TO DONATE TO THE MARK IBSEN GOFUNDME DEFENSE FUND, WHERE THE SON ALWAYS RISES!!!

FOR NOW, YOU ARE WITHIN

THE NORMS